Correction to: Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer’s disease: study protocol for a randomised controlled trial (ELAD study)
Grazia Daniela Femminella(Hammersmith Hospital), Paul Edison(Imperial College London), Benjamin R. Underwood(University of Cambridge), Sajeev Kshemendran, Ramin Nilforooshan(University of Surrey), Basil H. Ridha(University Hospitals Sussex NHS Foundation Trust), Clive Ballard(University of Exeter), Craig Ritchie(Western General Hospital), Paul Koranteng(Northamptonshire Healthcare NHS Foundation Trust), David J. Brooks(Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas), Bernadette McGuinness(Queen's University Belfast), Sharon Love(Nuffield Orthopaedic Centre), Andrew Donaldson(University of Cape Town), John Harrison(King's College London), Kehinde Junaid(Nottinghamshire Healthcare NHS Foundation Trust), Brady McFarlane(Southern Health NHS Foundation Trust), Naghma Malik(North West Boroughs Healthcare NHS Foundation Trust), George Tadros(Aston University), Clive Holmes(University of Eastern Finland), Christian Hölscher(Shanxi Medical University), Ajay Macharouthu(Crichton Royal Hospital), Gail Busza(Imperial College London), Simon Thacker, Zuzana Walker(South Essex Partnership University Foundation NHS Trust), Eleni Frangou(Nuffield Orthopaedic Centre), Gregor Russell(Bradford District Care NHS Foundation Trust), Hilary Archer(North Bristol NHS Trust), Vandana Mate(Cornwall Partnership NHS Foundation Trust), Robert M. Lawrence(South West London and St George's Mental Health NHS Trust), Anthony Peter Passmore(Queen's University Belfast), Carol Bannister(Warneford Hospital), Aparna Prasanna(Black Country Partnership NHS Foundation Trust), Elizabeth Coulthard(North Bristol NHS Trust), Lucy Knight(Somerset Partnership NHS Foundation Trust), Salman Karim(Lancashire Care NHS Foundation Trust)
Cited by 13
Related Papers
Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science
|The Lancet Psychiatry|2020|6k
Diagnosis and management of dementia with Lewy bodies
|Neurology|2017|4.4k
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease
|Nature Genetics|2009|3.4k
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease
|Nature Genetics|2011|2.1k
Defeating Alzheimer's disease and other dementias: a priority for European science and society
|The Lancet Neurology|2016|1.7k